Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane P Hanger

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Neuropharmacology|October 1, 2013
A role for tau at the synapse in Alzheimer's disease pathogenesisAmy M Pooler, Wendy Noble, Diane P Hanger
Trends in Molecular Medicine|February 28, 2009
Tau phosphorylation: the therapeutic challenge for neurodegenerative diseaseDiane P Hanger, Brian H Anderton, Wendy Noble
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 22, 2007
Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanismRitchie Williamson, Alessia Usardi, Diane P Hanger, et al.
Journal of Neurochemistry|March 5, 2008
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeatsSelina Wray, Malcolm Saxton, Brian H Anderton, et al.
Biology Open|January 17, 2014
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3βGiulia Povellato, Richard I Tuxworth, Diane P Hanger, et al.
Scientific Reports|August 9, 2017
Inhibition of glycogen synthase kinase-3 by BTA-EG<sub>4</sub> reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's diseaseCara L Croft, Ksenia Kurbatskaya, Diane P Hanger, et al.
Frontiers in Psychiatry|March 23, 2011
Anti-inflammatory impact of minocycline in a mouse model of tauopathyClaire J Garwood, Jonathan D Cooper, Diane P Hanger, et al.
Frontiers in Neurology|July 13, 2013
The importance of tau phosphorylation for neurodegenerative diseasesWendy Noble, Diane P Hanger, Christopher C J Miller, et al.
Journal of Neurochemistry|October 3, 2007
Kinase activities increase during the development of tauopathy in htau miceIan Kelleher, Claire Garwood, Diane P Hanger, et al.
Acta Neuropathologica Communications|January 5, 2019
A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein responseTong Guo, Dina Dakkak, Teresa Rodriguez-Martin, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Neuropharmacology|October 1, 2013
A role for tau at the synapse in Alzheimer's disease pathogenesisAmy M Pooler, Wendy Noble, Diane P Hanger
Trends in Molecular Medicine|February 28, 2009
Tau phosphorylation: the therapeutic challenge for neurodegenerative diseaseDiane P Hanger, Brian H Anderton, Wendy Noble
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 22, 2007
Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanismRitchie Williamson, Alessia Usardi, Diane P Hanger, et al.
Journal of Neurochemistry|March 5, 2008
Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeatsSelina Wray, Malcolm Saxton, Brian H Anderton, et al.
Biology Open|January 17, 2014
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3βGiulia Povellato, Richard I Tuxworth, Diane P Hanger, et al.
Scientific Reports|August 9, 2017
Inhibition of glycogen synthase kinase-3 by BTA-EG<sub>4</sub> reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's diseaseCara L Croft, Ksenia Kurbatskaya, Diane P Hanger, et al.
Frontiers in Psychiatry|March 23, 2011
Anti-inflammatory impact of minocycline in a mouse model of tauopathyClaire J Garwood, Jonathan D Cooper, Diane P Hanger, et al.
Frontiers in Neurology|July 13, 2013
The importance of tau phosphorylation for neurodegenerative diseasesWendy Noble, Diane P Hanger, Christopher C J Miller, et al.
Journal of Neurochemistry|October 3, 2007
Kinase activities increase during the development of tauopathy in htau miceIan Kelleher, Claire Garwood, Diane P Hanger, et al.
Acta Neuropathologica Communications|January 5, 2019
A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein responseTong Guo, Dina Dakkak, Teresa Rodriguez-Martin, et al.
Pageof 7